Contingency Management: A Reward-Based Approach to Addiction Treatment

Naomi Carr
Dr. Jennie Stanford
Written by Naomi Carr on 04 December 2024
Medically reviewed by Dr. Jennie Stanford on 09 December 2024

Contingency management involves rewarding individuals for positive behaviors during substance use disorder treatment. There is a great deal of evidence to indicate its effectiveness, showing improvements in abstinence and treatment retention.

Key takeaways:
  • Contingency management is a reward-based treatment to help people reduce addictive behaviors and improve their treatment engagement.
  • It can be implemented in any treatment setting, such as inpatient or outpatient treatments, methadone clinics, and partial hospitalization programs.
  • Different treatment providers will offer a range of treatment approaches so it can be helpful to contact them directly to find out more about their available programs.
a series of blocks moving upward with a block at the end of it that signifies a reward

What is contingency management?

Contingency management (CM) is a type of behavioral therapy that helps people to alter their behaviors through positive reinforcement. Rewards are given when positive behaviors are demonstrated, such as vouchers for retail items or services.

CM is based on operant conditioning, developed by B.F. Skinner in 1937. Operant conditioning states that behaviors can be adapted or controlled based on consequences and reinforcements.

CM uses this evidence-based technique to help people with substance use disorders (SUDs) change their addictive behaviors and improve their motivation to stay in treatment.

It is common for people with substance use issues to experience changing levels of motivation and some ambivalence around their sobriety, which is often one of the main reasons for treatment nonadherence, dropouts, and possibly relapse. CM can help improve adherence by promoting change and positive behaviors with rewards.

First, a behavior will be identified, such as abstaining from the substance, attending treatment sessions, or medication compliance. This behavior will be easily identifiable and quantifiable so that when it occurs, a reward is given, and when it does not, the reward is withheld.

Usually, one behavior will be adapted at a time, so the individual has the opportunity to receive rewards regularly and is not overwhelmed with numerous changes at once, which may set them up to fail.

How it works: Voucher-based reinforcement

CM can be provided via a voucher-based reinforcement program or a prize incentives program. Voucher-based reinforcement involves being rewarded with vouchers of different monetary values for food, shopping, or entertainment. The value of these vouchers might start small and be increased as the individual repeatedly engages in the targeted behaviors (for example abstinence or attendance).

Prize incentive programs may involve the individual being rewarded with a number of draws from the ‘fishbowl’ to receive a prize. This could be cash or gift vouchers of ranging values, such as from $1 to $100. With longer treatment engagement or abstinence, the number of draws the individual is rewarded with might increase, leading to a greater number of prizes.

Contingency management in addiction treatment

CM can be utilized in a range of treatment settings, although the targeted behaviors may differ. These programs can be implemented in inpatient, outpatient, partial hospitalization, or intensive outpatient programs to reinforce positive behaviors. It may be beneficial for these rewards to be given in group settings so others can witness their peers winning prizes and vouchers, thereby providing more incentives to succeed.

For example, in outpatient treatment, it may be difficult to monitor drug abstinence as this would require regular testing. As such, CM might be focused on attendance rather than abstinence.

In contrast, people in inpatient treatment or partial hospitalization programs could be tested several times a week. As such, they can be rewarded for periods of abstinence, with rewards increasing in value as the duration of abstinence increases.

CM has been found effective in any treatment setting, regardless of the individual’s characteristics or health issues.

What to expect in contingency management programs

CM programs will vary depending on the setting in which they are implemented and the individual’s treatment needs. However, most programs will involve certain expectations of the individual, such as:

  • Signing a contract that details expected behaviors, such as abstinence or attending sessions, and the rewards they can expect to receive for engaging in these behaviors.
  • Regular testing, which may be every few days.
  • Engaging in other treatments, such as cognitive behavioral therapy (CBT), to manage underlying causes and emotional issues and learn positive coping strategies.
  • Maintained abstinence, improved treatment engagement, and increased motivation.

Benefits of contingency management

CM can be one of the most effective treatment interventions in treating SUDs. A meta-analysis of various treatments found that CM was the most effective intervention for abstinence and treatment retention among SUDs.

Another study found that treatment retention was higher among the CM group than the standard care group, with 49% completing a 12-week program in the CM group, compared to 35% in the standard care group. It also demonstrated that abstinence was around four times higher in the CM group than in standard care (18.7% vs. 4.9%).

Other benefits of CM include:

Limitations and ethical considerations in contingency management

Some professionals and individuals consider ethical issues and limitations of CM to include:

  • Believing it is not effective and therefore they won’t use these strategies within their treatment plans
  • High costs of providing rewards, regular testing, and clinician time
  • It does not address the underlying causes of substance use
  • External rewards impact intrinsic behavior – the individual only changes their behavior to receive the reward but does not internally desire the changes, suggesting that once the reward is removed, the negative behavior returns
  • CM programs that involve negative punishments harm therapeutic relationships, are not liked by clinicians or patients, and increase dropout rates

However, these issues are mostly found to be opinions or myths and can be contradicted by the range of research and evidence that shows the benefits of CM.

Getting started with contingency management

When looking for a treatment center, there are several things to consider, including the severity and type of substance use, the type of treatment that is required, and the costs of treatment. After finding appropriate treatment providers, it may be beneficial to contact them directly to ask about their specific treatment approaches and whether they provide CM alongside other interventions.

FAQs

Common questions about contingency management

Is contingency management effective for all types of substance use disorders?

Yes, CM can be an effective treatment for all types of SUD.

How are rewards decided in a CM program?

Rewards given in a CM program may depend on the availability of finances at the clinic or facility. Typically, higher-value rewards are given as the individual engages in positive behaviors for longer durations.

How long does a typical program last?

The duration of this treatment approach will vary depending on the progress of the individual. Typically, programs will last around 12 weeks.

Was this page helpful?

Your feedback allows us to continually improve our information

Resources:

  1. Brown, H. D., & DeFulio, A. (2020). Contingency management for the treatment of methamphetamine use disorder: A systematic review. Drug and alcohol dependence, 216, 108307.
  2. Petry, N.M. (2011). Contingency Management: What It Is and Why Psychiatrists Should Want To Use It. The Psychiatrist, 35(5), 161–163. Retrieved from
  3. Skinner, B.F. (1937). Two Types of Conditioned Reflex: A Reply to Konorski and Miller. Journal of General Psychology, 16, 272-279. Retrieved from
  4. Higgins, S.T., & Petry, N.M. (1999). Contingency Management. Incentives for Sobriety. Alcohol Research & Health: The Journal of the National Institute on Alcohol Abuse and Alcoholism, 23(2), 122–127. Retrieved from
  5. Higgins, S.T., Silverman, K., & Heil, S.H. (2008). Contingency Management in Substance Abuse Treatment. The Guilford Press.
  6. Petry, N.M. (2000). A Comprehensive Guide to the Application of Contingency Management Procedures in Clinical Settings. Drug and Alcohol Dependence, 58(1-2), 9–25. Retrieved from
  7. Pfund, R.A., Ginley, M.K., Rash, C.J., & Zajac, K. (2022). Contingency Management for Treatment Attendance: A Meta-Analysis. Journal of Substance Abuse Treatment, 133, 108556. Retrieved from
  8. Petry, N.M., Alessi, S.M., Olmstead, T.A., Rash, C.J., & Zajac, K. (2017). Contingency Management Treatment for Substance Use Disorders: How Far Has it Come, and Where Does it Need to Go? Psychology of Addictive Behaviors: Journal of the Society of Psychologists in Addictive Behaviors, 31(8), 897–906. Retrieved from
  9. Kelly, T.M., Daley, D.C., & Douaihy, A.B. (2014). Contingency Management for Patients with Dual Disorders in Intensive Outpatient Treatment for Addiction. Journal of Dual Diagnosis, 10(3), 108–117. Retrieved from
  10. Dutra, L., Stathopoulou, G., Basden, S.L., Leyro, T.M., Powers, M.B., & Otto, M.W. (2008). A Meta-Analytic Review of Psychosocial Interventions for Substance Use Disorders. The American Journal of Psychiatry, 165(2), 179–187. Retrieved from
  11. Petry, N. M., Peirce, J. M., Stitzer, M. L., et al. (2005). Effect of Prize-Based Incentives on Outcomes in Stimulant Abusers in Outpatient Psychosocial Treatment Programs: A National Drug Abuse Treatment Clinical Trials Network Study. Archives of General Psychiatry, 62(10), 1148–1156. Retrieved from
  12. Petry, N.M. (2010). Contingency Management Treatments: Controversies and Challenges. Addiction (Abingdon, England), 105(9), 1507–1509. Retrieved from

Activity History - Last updated: 09 December 2024, Published date:


Reviewer

Dr. Jennie Stanford

MD, FAAFP, DipABOM

Jennie Stanford, MD, FAAFP, DipABOM is a dual board-certified physician in both family medicine and obesity medicine. She has a wide range of clinical experiences, ranging from years of traditional clinic practice to hospitalist care to performing peer quality review to ensure optimal patient care.

Activity History - Medically Reviewed on 21 November 2024 and last checked on 09 December 2024

Related guides